Displaying all 3 drugs
Insulin glargine
Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the...
Approved
Matched Synonyms: … Insulin glargine ... insulin glargine-yfgn ... Insulin glargine recombinant …
Matched Name: … Insulin glargine …
Matched Description: … Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type ... As a result, people with T1D rely primarily on exogenous forms of insulin, such as insulin glargine, ... Available as the brand name product Lantus, insulin glargine has a duration of action up to 24 hours …
Matched Categories: … insulin glargine ... insulin glargine and lixisenatide …
Matched Products: … Insulin Glargine ... Insulin glargine U-300 ... Insulin Glargine Solostar …
Matched Name: … Insulin glargine …
Matched Description: … Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type ... As a result, people with T1D rely primarily on exogenous forms of insulin, such as insulin glargine, ... Available as the brand name product Lantus, insulin glargine has a duration of action up to 24 hours …
Matched Categories: … insulin glargine ... insulin glargine and lixisenatide …
Matched Products: … Insulin Glargine ... Insulin glargine U-300 ... Insulin Glargine Solostar …
Lixisenatide
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Approved
Matched Categories: … insulin glargine and lixisenatide …
Beinaglutide
Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).
Investigational
Matched Description: … Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine …
Displaying all 3 drugs